NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
Back to search
Official data from USPTO
RG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
06/11/2024
Trademark type
Combined
Nice classes
5
Filing date
08/24/2021
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/09/2024
First use in commerce
02/09/2024
Drawing code
3
Owner type
99
Owner location
Suzhou, Jiangsu, CN
Examiner
STEEL, ALYSSA
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized illustration of the letters "R" and "G", which illustration is also meant to be a stylized presentation of the DNA double helix structure.
Holders and representatives
Holders
RinuaGene Biotechnology Co., Ltd.
Representatives
Eric Lamb Frost Brown Todd LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicalbiologicalpharmaceuticalveterinary preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseasescancersneurological disorderscardiovascular disordersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders and reproductive disorders;medicalbiologicalpharmaceuticalveterinary preparations for medical and pharmaceutical usepreparations for preventing and treating rare diseasescancersneurological disorderscardiovascular disordersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disordersreproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivoex vivoon vivo delivery to cell sites; cell-based immunotherapeutic treatment by way of genetically modified cellsmedicated serums for the treatment of rare diseasescancersneurological disorderscardiovascular disordersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders and reproductive disorders; attenuated viruses and particles similar to virusesencapsulated nucleic acids for the treatment of rare diseasescancersneurological disorderscardiovascular disordersinflammatory disordersimmunoregulatory disordersmetabolic disordersinfectious disorders and reproductive disorders; diagnostic reagents and diagnostic preparations for medical purposes; chemical reagents used for medical or veterinary purposes; biochemical reagents used for medical or veterinary purposes for the treatment of cancertreatment of immunological diseasestreatment of infectious diseases; adjuvants for medical purposes; macromoleculesnucleic acid sequences and proteinsused for medical and veterinary purposes; a full line of pharmaceuticalsvaccinesmedicinesbiologicsbiotherapeuticsbiosimilars and therapeutics for the treatment of infectious diseases and cancer; vaccines; a full line of pharmaceuticalsmedicinesbiologicsbiotherapeuticsbiosimilars and therapeutics for the treatment of infectious diseases and cancer
Publications
History of USPTO decisions and trademark events.
48 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/09/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/09/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/08/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
05/08/2024
EX3G
SOU EXTENSION 3 GRANTED
05/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/23/2024
IUAF
USE AMENDMENT FILED
04/12/2024
DRRR
DIVISIONAL REQUEST RECEIVED
04/12/2024
EXT3
SOU EXTENSION 3 FILED
04/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
04/12/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/13/2023
EX2G
SOU EXTENSION 2 GRANTED
10/11/2023
EXT2
SOU EXTENSION 2 FILED
10/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2023
DOCK
ASSIGNED TO EXAMINER
10/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/17/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/17/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/17/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/22/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2023
EX1G
SOU EXTENSION 1 GRANTED
03/20/2023
EXT1
SOU EXTENSION 1 FILED
03/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/18/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/23/2022
PUBO
PUBLISHED FOR OPPOSITION
08/23/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2022
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
07/15/2022
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
07/15/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/15/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/15/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/15/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2022
GNRT
NON-FINAL ACTION E-MAILED
06/09/2022
CNRT
NON-FINAL ACTION WRITTEN
06/09/2022
DOCK
ASSIGNED TO EXAMINER
05/26/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/10/2021
NWAP
NEW APPLICATION ENTERED
08/27/2021
Continuous trademark protection
Get notified about every new filing that threatens RG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.